Office of Therapeutics Alliances (OTA)
Image above has clickable areas
The Office of Therapeutics Alliances (OTA), within the Office of Science and Research (OSR), was established to facilitate the translation of cutting-edge, medically relevant research conducted at NYU into new therapeutics, increased licensing and productive academic-industry interactions. OTA works with NYU investigators to bridge the translation gap between academia and industry by providing a continuum of resources to support key activities in early stage drug discovery. OTA resources include funding, as well as access to external capabilities in medicinal chemistry, pharmacology, pharmacokinetics, toxicology, and early stage drug development. OTA activities focus on increasing the value of NYU emerging technologies and therapeutics to enable successful licensing and partnerships with existing and startup biopharma companies.